PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

SKI2162, an inhibitor of the TGF-beta type I receptor (ALK5), inhibits radiation-induced fibrosis in mice.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25686821 ↗2015Reported benefit

SKI2162, an inhibitor of the TGF-beta type I receptor (ALK5), inhibits radiation-induced fibrosis in mice.

MouseRadiationBALB/cMalen = Systemic study: saline n = 20, SKI2162 n = 21, pentoxifylli…Intraperitoneal for SKI2162 and pentoxifylline, oral for tocopherol, and topical application to the irradiated site10 mg/kg systemically; topical formulations of 0.1 per cent…Initiated immediately after irradiation

Model: Radiation-induced fibrosis of the left hind limb, delivered as two weekly 22 Gy fractions by linear accelerator; the topical experiment used a single 35 Gy dose

SKI2162 inhibited ALK5 with an IC50 of 0.094 micromolar and abolished TGF-beta1-induced Smad2 and Smad3 phosphorylation at 400 nanomolar. In mice it significantly reduced leg contracture from 6 to 16 weeks, lowered the 16-week late skin reaction score to 2.73 plus or minus 0.16 versus 3.14 plus or…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.